19 results on '"Ulmann, Vit"'
Search Results
2. River Sediments Downstream of Villages in a Karstic Watershed Exhibited Increased Numbers and Higher Diversity of Nontuberculous Mycobacteria
3. The impact of residential villages in a karstic watershed on numbers and diversity of nontuberculous mycobacteria
4. Prevalence of Non-Tuberculous Mycobacteria in Gestating Common Noctule (Nyctalus noctula) Females.
5. Nontuberculous mycobacteria in the environment of Hranice Abyss, the world’s deepest flooded cave (Hranice karst, Czech Republic)
6. Nontuberculous Mycobacteria: Ecology and Impact on Animal and Human Health
7. Nontuberculous Mycobacteria as Sapronoses: A Review
8. The Impact of Municipalities on Numbers and Diversity of Nontuberculous Mycobacteria in Small Watercourses of a Karstic Watershed
9. Nontuberculous Mycobacteria Prevalence in Aerosol and Spiders’ Webs in Karst Caves: Low Risk for Speleotherapy
10. Clinical Relevance and Environmental Prevalence of Mycobacterium fortuitum Group Members. Comment on Mugetti et al. Gene Sequencing and Phylogenetic Analysis: Powerful Tools for an Improved Diagnosis of Fish Mycobacteriosis Caused by Mycobacterium fortuitum Group Members. Microorganisms 2021, 9, 797
11. Nontuberculous Mycobacteria Prevalence in Bats’ Guano from Caves and Attics of Buildings Studied by Culture and qPCR Examinations
12. Recovery of Mycobacteria from Heavily Contaminated Environmental Matrices
13. MALDI Spectra Database for Rapid Discrimination and Subtyping of Mycobacterium kansasii
14. MALDI Spectra Database for Rapid Discrimination and Subtyping of Mycobacterium kansasii
15. Avian Mycobacteriosis: Still Existing Threat to Humans
16. Mycobacteria in Water Used for Personal Hygiene in Heavy Industry and Collieries: A Potential Risk for Employees
17. Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing–remitting multiple sclerosis
18. Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing–remitting multiple sclerosis.
19. Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.